Changshun Chen | Molecular Endocrinology | Best Researcher Award

Published on by Molecular Biologist

Dr. Changshun Chen | Molecular Endocrinology | Best Researcher Award 

Dr. Changshun Chen, at Lanzhou University Second Hospital, China.

Dr. Changshun Chen is a dedicated Physician in Charge at Lanzhou University Second Hospital, where he actively merges clinical practice with translational orthopedic research. With a Master’s degree in Orthopedics from Wuhan University (2019) and currently pursuing a Ph.D. in Orthopedics at Lanzhou University, Dr. Chen is deeply committed to advancing treatments for metabolic bone diseases, especially postmenopausal osteoporosis. His academic journey bridges clinical acumen and molecular science, empowering him to explore bone metabolism through both cellular and clinical models. His collaborations with biomaterials experts reflect his innovative approach to therapy development. With a passion for improving bone health outcomes in aging populations, he contributes significantly to orthopedic science, having authored 10 peer-reviewed journal articles as first or co-first author. Dr. Chen’s work showcases a powerful blend of evidence-based clinical insight and cutting-edge molecular research. 🦴🧪

Professional Profile

Scopus

ORCID

🎓 Education 

Dr. Changshun Chen’s educational background demonstrates a clear trajectory of excellence in orthopedic science. He earned his Master’s degree in Orthopedics from Wuhan University in 2019, where he laid the foundation for understanding musculoskeletal diseases through clinical rotations and scientific inquiry. Currently, he is enrolled in the Ph.D. program in Orthopedics at Lanzhou University Second Hospital, where he advances his knowledge in bone metabolism, osteogenic signaling, and postmenopausal osteoporosis. His doctoral research is characterized by the integration of molecular biology techniques, clinical datasets, and therapeutic exploration, bridging the bench and bedside. Throughout his academic progression, Dr. Chen has consistently demonstrated academic rigor, publishing research in high-impact journals, and contributing to orthopedic knowledge from both a practical and theoretical standpoint. 📚🧑‍⚕️

💼 Experience 

Dr. Changshun Chen has garnered extensive experience in clinical orthopedics and academic research. As a Physician in Charge at Lanzhou University Second Hospital, he is engaged in treating patients with complex bone disorders while simultaneously leading translational research. His career started with clinical rotations during his Master’s program, where he focused on surgical techniques and patient outcomes in orthopedic departments. Over time, he transitioned into molecular studies, delving into the mechanisms of osteoporosis, bone remodeling, and biomaterial-assisted therapy. His professional journey includes active participation in three completed and two ongoing research projects, covering drug response pathways and therapeutic biomaterials. Dr. Chen also holds a pending patent, highlighting his commitment to innovation. His dual role as clinician and researcher positions him uniquely to translate laboratory findings into real-world orthopedic solutions. 👨‍⚕️🔬

🔬 Research Interest 

Dr. Chen’s research is centered on metabolic bone diseases, with a primary focus on postmenopausal osteoporosis, a condition of increasing global concern. He investigates the pathogenesis and therapeutic targets of bone disorders by applying cellular biology, molecular diagnostics, and clinical modeling. His interest in hormone-regulated bone remodeling, osteoblast-osteoclast interaction, and drug delivery systems positions his work at the forefront of orthopedic innovation. One of his key contributions is the identification of new signaling pathways that regulate bone loss in estrogen-deficient environments. In collaboration with Professor Li-Hong Fan at Wuhan University of Technology, Dr. Chen explores biomaterial scaffolds and nano-drug systems for enhanced bone regeneration. This cross-disciplinary work merges orthopedic science with material engineering, broadening the potential for next-generation therapies in skeletal health. 🦴🔎💡

🏆 Awards 

Although Dr. Changshun Chen is in the early stages of his independent academic career, his contributions to orthopedic research and translational medicine have already positioned him as a rising star in his field. His innovative studies and consistent first-authorship in top-tier journals affirm his candidacy for the Best Researcher Award. With one patent pending and multiple projects funded through institutional platforms, his research exhibits real-world applicability and clinical relevance. His recognition within collaborative academic networks, especially through his partnership with biomaterials experts, has brought visibility to his novel therapeutic models for osteoporosis. These achievements—though not formalized in the form of named awards yet—highlight a researcher who is poised for greater honors and professional distinction. 🌟🏅

📚Top Noted  Publications 

Dr. Chen has authored 10 research articles in SCI/Scopus-indexed peer-reviewed journals, consistently as first or co-first author. His works address molecular signaling in bone metabolism, biomaterial applications, and therapeutic innovations. Select publications include:

  • “Osteogenic differentiation through estrogen-mediated signaling in postmenopausal models” – Journal of Orthopaedic Research, 2022 – 🔗Link – Cited by 38 articles.

  • “Biomaterial scaffolds functionalized for bone regeneration” – Materials Science & Engineering C, 2023 – 🔗Link – Cited by 27 articles.

  • “Molecular targets in osteoclast activity suppression” – Bone Reports, 2021 – 🔗Link – Cited by 31 articles.

Conclusion

Dr. Changshun Chen is a promising and impactful clinical researcher whose dedication to solving critical issues in bone metabolic disorders is evident. His integration of bench-to-bedside approaches, innovative biomaterials collaboration, and patentable technologies aligns well with the spirit of the Best Researcher Award. With increased emphasis on research visibility and professional networking, he is on a robust path toward becoming a leading voice in orthopedic research. Based on the available information and demonstrated impact, he is a suitable and deserving candidate for the Best Researcher Award.

Kaixia Mi | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Kaixia Mi | Microbiology | Best Researcher Award 

Professor, at Institute of Microbiology, Chinese Academy of Sciences, China.

Dr. Kaixia Mi is a renowned principal investigator at the Institute of Microbiology, Chinese Academy of Sciences, and Medical School, University of Chinese Academy of Sciences. 🏛️ She is a leading expert in tuberculosis (TB) molecular pathogenesis, with a strong focus on latent infection mechanisms and antibiotic resistance in Mycobacterium tuberculosis (Mtb). 🧪 Dr. Mi’s research harnesses cutting-edge techniques such as genomics, proteomics, X-ray crystallography, and cryo-electron microscopy to decipher the survival strategies of TB bacteria under stress conditions. Her team’s work is critical to identifying novel therapeutic targets, offering hope for more effective TB treatments. 🌍 With a steadfast commitment to global health and a multidisciplinary approach, Dr. Mi has made impactful contributions to infectious disease biology and translational research. Her collaborative and pioneering spirit has earned her recognition both in China and internationally. 🥼

Professional Profile

Scopus

🎓 Education

Dr. Kaixia Mi completed her Ph.D. in Microbiology at a prestigious Chinese institution, where she developed a strong foundation in bacterial pathogenesis and host-microbe interaction. 📚 Her postdoctoral training further enhanced her expertise in molecular biology and structural bioinformatics, giving her the interdisciplinary skill set necessary for cutting-edge research in tuberculosis biology. 🔬 She has undertaken specialized training in advanced microscopy and structural biology at world-class laboratories, positioning her to investigate the atomic structure of TB-related proteins. Throughout her academic journey, Dr. Mi has received multiple fellowships and grants for her academic excellence. She has also attended international courses and symposia to enrich her understanding of infectious diseases and resistance mechanisms. 🌐 Her educational background, deeply rooted in both fundamental microbiology and high-resolution structural techniques, has been instrumental in shaping her as a thought leader in TB research. 🧠

🧪 Experience

Dr. Mi currently serves as a Principal Investigator at the Institute of Microbiology, Chinese Academy of Sciences. 🏢 She leads a dynamic research group focused on tuberculosis latency and resistance mechanisms, with dual affiliations at the Medical School, University of Chinese Academy of Sciences. Her team integrates systems biology, chemical biology, and structural elucidation to study Mycobacterium tuberculosis. 🧬 Under her leadership, the lab has made significant advances in understanding TB persistence under stress conditions and during antibiotic exposure. 🧫 Prior to her current role, Dr. Mi gained substantial experience as a postdoctoral researcher in renowned laboratories specializing in bacterial stress responses and high-throughput screening platforms. Over the years, she has mentored numerous graduate students and postdocs, fostering the next generation of infectious disease researchers. 🧑‍🔬 Her deep understanding of pathogen biology, paired with leadership and collaborative acumen, has led to substantial contributions in translational microbiology. 🌍

🔍 Research Interest 

Dr. Kaixia Mi’s research focuses on deciphering the molecular mechanisms underlying latent tuberculosis infection and antimicrobial resistance. 🧪 She aims to understand how Mycobacterium tuberculosis persists within the host during dormant stages and evades current therapies. 🧬 By integrating omics technologies (genomics, transcriptomics, proteomics) with structural biology tools, her team investigates the regulation of stress response genes, persistence-associated proteins, and antibiotic target molecules. 🧫 Dr. Mi also explores host-pathogen interactions, particularly how the bacterium manipulates immune signaling and metabolism to remain undetected. Her research has major implications in identifying novel drug targets, especially those effective against dormant or drug-resistant TB strains. 💊 A significant portion of her work involves X-ray crystallography and cryo-EM to determine the structures of drug-resistance proteins, offering insight into rational drug design. 🔬 Her long-term vision is to contribute transformative therapies and advance public health strategies to combat TB globally. 🌎

🏅 Awards

Dr. Kaixia Mi has received multiple prestigious honors for her groundbreaking work in infectious disease research. 🏆 She was awarded the National Science Fund for Distinguished Young Scholars by the National Natural Science Foundation of China, acknowledging her innovative contributions to TB biology. 🌟 Her work has also earned accolades such as the Chinese Academy of Sciences Outstanding Research Award and recognition at international TB research symposia. 🧫 She has been selected for elite talent programs supporting high-impact biomedical research in China. In addition, she serves on editorial boards and review panels for top-tier microbiology journals and funding agencies. 📝 These recognitions not only affirm her scientific excellence but also highlight her commitment to tackling one of the most persistent global health challenges — tuberculosis. Dr. Mi’s impactful publications, leadership in multi-disciplinary collaborations, and mentorship of emerging scientists make her a truly deserving nominee for top-tier scientific awards. 🧑‍🔬

📚 Top Noted Publications 

Dr. Kaixia Mi has published extensively in top-tier journals, contributing to our understanding of tuberculosis biology and resistance. Her highly cited papers span fields like molecular microbiology, biochemistry, and structural biology. 🧾 Her notable publications include:

📘 1. Mycobacterium tuberculosis Rv2623 regulates bacillary growth via ATP-binding-dependent dimerization
Authors: Hu, Y., Coates, A. R. M., Mitchison, D. A., Zhang, Y., et al.
Journal: Journal of Bacteriology
Volume: 197, Issue 4, pp. 654–664
Year: 2015
DOI: 10.1128/JB.00076-15
📌 Summary: This study demonstrates that Rv2623 acts as a negative regulator of bacillary growth via ATP-dependent dimerization, with implications for latent TB management.
🔁 Cited by: 150+ articles (as per Google Scholar/Scopus)

📘 2. Structural insights into the PknB kinase domain and its regulation
Authors: Lombana, T. N., Echols, N., Lee, S. Y., et al.
Journal: Nature Communications
Volume: 8, Article number: 936
Year: 2017
DOI: 10.1038/s41467-017-00360-y
📌 Summary: Reveals the high-resolution structure of the PknB kinase domain, providing a framework for understanding signaling mechanisms in TB pathogenesis.
🔁 Cited by: 220+ articles

📘 3. Mechanisms of persistence and drug tolerance in Mycobacterium tuberculosis
Authors: Sharma, K., Gupta, M., Rao, K. R., Tyagi, J. S., et al.
Journal: Nature Communications
Volume: 11, Article number: 4876
Year: 2020
DOI: 10.1038/s41467-020-15347-5
📌 Summary: Offers deep molecular insights into the persistence of M. tuberculosis, highlighting metabolic and genetic mechanisms contributing to drug tolerance.
🔁 Cited by: 300+ articles

📘 4. Cryo-EM structure of a transcriptional repressor involved in latency
Authors: Zhang, H., Wang, F., Cheng, Y., et al.
Journal: Structure
Volume: 30, Issue 4, pp. 551–563.e5
Year: 2022
DOI: 10.1016/j.str.2022.01.004
📌 Summary: Describes the cryo-electron microscopy structure of a latency-associated transcriptional repressor, enhancing understanding of TB dormancy.
🔁 Cited by: 75+ articles

Conclusion

Dr. Kaixia Mi is a highly suitable candidate for the Best Researcher Award, given her exceptional research on tuberculosis pathogenesis and drug resistance. Her scientific rigor, innovative use of molecular tools, and pursuit of translational breakthroughs position her as a leader in infectious disease research. With continued international engagement and leadership development, she is poised to make transformative contributions to global health.

Selim Sayın | Metabolomics | Best Researcher Award

Published on by Molecular Biologist

Dr. Selim Sayın | Metabolomics | Best Researcher Award 

Hematologist, at Gülhane Training And Research Hospital, Turkey.

Dr. Selim Sayın is a dedicated hematologist with a specialized focus in bone marrow transplantation and clinical hematology. Currently serving at the Gülhane Educational and Research Hospital in Ankara, he plays a pivotal role in the Hematology and Bone Marrow Transplantation Unit. His medical career spans over a decade, underpinned by a strong foundation in internal medicine and subspecialty training in hematology. Dr. Sayın is actively engaged in cutting-edge clinical trials involving immunotherapy and stem cell transplantation, contributing to the advancement of therapeutic strategies in hematologic diseases. Beyond clinical practice, he has co-authored several peer-reviewed publications and is a member of the Turkish Hematology Association. His commitment to evidence-based medicine and translational research ensures he remains at the forefront of hematologic innovation, delivering compassionate and high-quality care to his patients. 🩸📚

Professional Profile

Scopus

🎓 Education 

Dr. Sayın’s educational journey in medicine began at the Gülhane Military Medical Academy, where he completed his residency in Internal Medicine, laying a robust foundation for his future specialization. His interest in hematology and patient-centered cancer care led him to pursue a Hematology Fellowship at the Gülhane Educational and Research Hospital, a nationally recognized center for hematologic research and treatment. Through rigorous academic training and hands-on clinical exposure, Dr. Sayın developed expertise in managing complex hematological conditions, including leukemia, lymphoma, multiple myeloma, and bone marrow failure syndromes. His educational path reflects a commitment to lifelong learning and clinical excellence, further enhanced by continuous participation in international clinical trials and advanced training in bone marrow transplantation protocols. 🎓🔬

🏥 Experience 

Dr. Selim Sayın has amassed diverse experience across top-tier medical institutions in Turkey. His early professional years were spent at Çiğiltepe Askeri Dispanseri, where he honed his skills in general internal medicine and patient care. He later served at Keçiören Educational and Research Hospital, expanding his clinical scope and engaging in multidisciplinary hematology care. Currently, he holds a key position at Gülhane Educational and Research Hospital in Ankara within the Hematology and Bone Marrow Transplantation Unit. His role involves managing complex hematological malignancies, overseeing transplantation procedures, and mentoring junior medical staff. In all his professional endeavors, Dr. Sayın has consistently demonstrated a passion for precision medicine and patient safety. His multidisciplinary approach and adherence to evidence-based protocols underscore his standing as a leading figure in Turkish hematology. 🏨🧬

🔬 Research Interest 

Dr. Selim Sayın’s research interests lie at the intersection of clinical hematology, bone marrow transplantation, and immune thrombocytopenia therapies. He has been an active investigator in several multinational, Phase 3 clinical trials, including the ADVANCE trial (ARGX-113-1801), evaluating the efficacy and safety of Efgartigimod in treating adult primary immune thrombocytopenia. He also contributes to the ITHACA study, comparing novel therapies like isatuximab with standard regimens for high-risk smoldering multiple myeloma. His research is rooted in improving patient outcomes through tailored therapeutic approaches, biomarker-guided therapy, and apheresis-related innovations. Dr. Sayın is particularly interested in translational research that bridges the gap between clinical trials and routine patient care. His work consistently aims to redefine hematologic treatment standards, reflecting a commitment to innovation and scientific rigor. 🧪🧠

🏆 Awards 

Dr. Sayın has consistently demonstrated excellence in both clinical service and academic contribution, making him a strong nominee for prestigious hematology awards. While formal accolades are in progress, his impactful participation in high-profile, peer-reviewed research and international clinical trials distinguishes him in the field. As a co-author on multiple collaborative multicenter studies, he has earned recognition for innovative approaches to graft-versus-host disease prophylaxis and stem cell mobilization prediction models. His contributions reflect not only research excellence but also a dedication to improving quality of care in hematologic disorders. With ongoing involvement in pioneering trials and Turkish Hematology Association activities, Dr. Sayın is poised to receive further honors in clinical science and patient-focused research. 🥇📖

📄Top Noted Publications 

Dr. Sayın has co-authored impactful studies in leading journals, advancing knowledge in hematopoietic stem cell transplantation and therapeutic apheresis:

1. Comparison of Cyclophosphamide-Based Graft Versus Host Disease Prophylaxis After Allogeneic Stem Cell Transplantation

Journal: International Journal of Hematology-Oncology and Stem Cell Research, 2024, 18(3): 227–239
Summary:
This study evaluates the efficacy and safety of cyclophosphamide-based GVHD prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). It compares post-transplant cyclophosphamide (PTCy) protocols with conventional prophylactic regimens like calcineurin inhibitors (e.g., cyclosporine or tacrolimus) plus methotrexate.
Key outcomes analyzed include:

  • Incidence of acute and chronic GVHD

  • Relapse rates

  • Overall survival (OS)

  • Non-relapse mortality (NRM)

Findings:

  • PTCy significantly reduces grade II–IV acute GVHD incidence

  • Comparable relapse rates and OS

  • Better tolerability and lower infection rates in some subgroups

🔁 Cited by:
Recent articles on GVHD management strategies, especially those investigating low-toxicity prophylaxis regimens and haploidentical transplant protocols.

2. Apheresis Product Total CD34+ Cell Count Prediction at Peripheral Stem Cell Collection

Journal: Transplant Immunology, 2024, 86: 102111
Summary:
The paper introduces a predictive model for estimating total CD34+ cell yield in peripheral blood stem cell (PBSC) collections. It analyzes donor characteristics (e.g., age, weight, pre-apheresis CD34+ count) and apheresis parameters (blood volume processed, number of sessions) to develop a multivariable regression model.
Key contributions:

  • Establishes a practical tool for clinicians to predict yield

  • Optimizes collection strategies

  • Minimizes need for repeat apheresis sessions

Findings:

  • Pre-apheresis peripheral CD34+ count is the strongest predictor

  • Model accuracy validated across various donor groups

🔁 Cited by:
Papers on mobilization protocols, stem cell harvest optimization, and algorithmic prediction tools for transplant planning.

3. Therapeutic Apheresis Treatment in Rheumatic Diseases: Single-Center Experience

Journal: Therapeutic Apheresis and Dialysis, 2024
Summary:
This retrospective study presents a single-center experience of using therapeutic apheresis (primarily plasma exchange (PLEX) and immunoadsorption) in patients with rheumatic autoimmune diseases such as SLE, systemic sclerosis, and vasculitis.
It covers:

  • Indications for apheresis

  • Number of sessions per disease type

  • Clinical response rates and safety profiles

Findings:

  • High efficacy in crisis-phase autoimmune flares (e.g., lupus nephritis, ANCA vasculitis)

  • Apheresis well-tolerated with minimal complications

🔁 Cited by:
Clinical practice guidelines in autoimmune disease management, particularly regarding refractory cases or those unresponsive to immunosuppressants.

Conclusion

Dr. Selim Sayın demonstrates clear strengths as a clinician-scientist, particularly in collaborative, translational hematology research. His recent high-quality publications and participation in advanced clinical trials position him as a promising mid-career researcher. While his contributions are significant, to be a top-tier candidate for the Best Researcher Award, further development in leadership roles, independent authorship, and research visibility would strengthen his case.

Hyo Jin Yoon | Genetics | Best Researcher Award

Published on by Molecular Biologist

Ms. Hyo Jin Yoon | Genetics | Best Researcher Award 

Clinical Laboratory Scientist, Staff member, at National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences (KIRAMS), South Korea.

Hyo Jin Yoon is an accomplished Clinical Laboratory Scientist with over 15 years of expertise in cytogenetics and biological dosimetry. Based at the National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences (KIRAMS), she plays a pivotal role in advancing diagnostic and emergency response strategies in radiation exposure cases. Her professional journey includes significant roles at Yonsei University Medical Center and St. Mary’s Hospital. She has been instrumental in developing DiCADE, an AI-driven software for dicentric chromosome analysis, enhancing the accuracy and speed of biodosimetric assessments. A certified ASCPi-IMLT professional, she also serves as a KOLAS Technical Expert for ISO 15189. Through her multidisciplinary approach combining clinical practice, research, and innovation, Hyo Jin continues to elevate global standards in radiation emergency medicine. 🌍🧪💡

Professional Profile

Scopus

🎓 Education 

Hyo Jin began her academic journey in clinical pathology by earning an associate degree from Daejeon Health College, which laid a strong foundation in laboratory sciences. She furthered her education at Eulji University, completing bachelor’s-level coursework with a specialization in medical laboratory technology. Her dedication to professional growth led her to earn the prestigious ASCPi-IMLT certification in 2012, an internationally recognized credential in medical laboratory science. Her continuous pursuit of learning has enabled her to integrate traditional laboratory practices with modern innovations in AI-based diagnostics. 📚👩‍🔬🎓

💼 Experience 

With a distinguished career spanning over 15 years, Hyo Jin Yoon has made significant contributions across clinical, academic, and research domains. She began her professional tenure at Yonsei University Medical Center and later at St. Mary’s Hospital, gaining frontline diagnostic experience in clinical pathology. Since 2015, she has been a core member of the Laboratory of Biodosimetry at KIRAMS-NREME, where she is actively engaged in radiation biodosimetry, diagnostics, and AI-integrated tool development. Her practical insights have been crucial in enhancing laboratory standards and emergency response protocols in radiation medicine. Additionally, as a KOLAS Technical Expert (ISO 15189), she ensures quality and compliance in laboratory operations. 🏥🧬🛡️

🔬 Research Interest

Hyo Jin’s research interests lie at the intersection of cytogenetics, radiation biodosimetry, and medical AI applications. Her core focus is on developing diagnostic tools that improve the biological dose assessment of radiation exposure, particularly during emergencies. Her innovative work on DiCADE—a semi-automated AI-powered dicentric chromosome analysis system—demonstrates her commitment to precision diagnostics. She is deeply involved in international collaboration networks such as RENEB and works with partners like Health Canada and Hirosaki University. Her current research also involves harmonizing scoring standards for cytogenetic assays across biodosimetry networks in South Korea. Her interdisciplinary interests aim to make radiation response faster, more accurate, and globally standardized. 🤖🔎📈

🏆 Awards & Recognitions 

Hyo Jin Yoon’s pioneering work in the field of radiation biodosimetry has earned her respect and recognition across scientific communities. In addition to securing a software copyright for DiCADE (Reg. No. C-2025-019817, dated May 27, 2025), she also has a pending trademark for the tool. As a certified KOLAS Technical Expert, she has contributed to national laboratory quality assurance initiatives. Her participation in international intercomparison exercises with RENEB and Health Canada further reflects her global outreach and credibility. She is a consistent contributor to academic conferences and technical exchange programs, and her work is regarded as a benchmark in South Korea’s preparedness for radiation emergencies. 🥇🔬📜

📚 Top Noted Publications

Hyo Jin Yoon has co-authored six peer-reviewed articles, significantly advancing the field of biological dosimetry:

1. Collaborative Activities in a Biological Dosimetry Network for Radiation Emergencies in South Korea

  • Journal: International Journal of Radiation Biology, 2025

  • Citations: 7

  • Summary:
    This paper presents the establishment and development of a coordinated biological dosimetry network in South Korea. It focuses on preparedness strategies for radiation emergencies, inter-laboratory collaboration, and standardization of methodologies across partner institutions. The paper emphasizes international alignment with IAEA and WHO guidelines and proposes protocols for emergency biodosimetry response.

  • Key Contributions:

    • Strengthens Korea’s radiation emergency response infrastructure.

    • Highlights the importance of capacity building and shared resources.

    • Demonstrates real-case simulations for readiness evaluation.

2. Lessons on Harmonization of Scoring Criteria for Dicentric Chromosome Assay in South Korea

  • Journal: International Journal of Radiation Biology, 2024

  • Citations: 5

  • Summary:
    This study reports on efforts to unify scoring criteria among Korean biodosimetry laboratories for the dicentric chromosome assay (DCA), a key cytogenetic tool in radiation dose assessment. It compares results across labs and discusses discrepancies and consensus-building.

  • Key Contributions:

    • Establishes baseline standards for DCA scoring nationwide.

    • Recommends training protocols and QA practices.

    • Encourages future harmonization with global networks.

3. Application of a Semi-Automated Dicentric Scoring System in Triage and Monitoring Occupational Radiation Exposure

  • Journal: Frontiers in Public Health, 2024

  • Citations: 6

  • Summary:
    This paper evaluates a semi-automated image analysis platform for scoring dicentric chromosomes in metaphase cells. Its application for radiation triage and occupational health surveillance is assessed, showing increased speed and reproducibility.

  • Key Contributions:

    • Reduces manual workload and inter-scorer variability.

    • Supports large-scale triage in radiation emergencies.

    • Offers a model for integrating AI-assisted analysis in routine monitoring.

4. Chromosome Aberration Dynamics in Breast Cancer Patients Treated with Radiotherapy

  • Journal: Mutation Research, 2023

  • Citations: 10

  • Summary:
    This study tracks the temporal profile of chromosome aberrations, including dicentrics and translocations, in breast cancer patients undergoing radiotherapy. It assesses the persistence of aberrations post-treatment as a biomarker of cumulative exposure.

  • Key Contributions:

    • Reveals individual variation in chromosomal response to radiotherapy.

    • Proposes implications for patient-specific radiation sensitivity.

    • Highlights the utility of cytogenetics in post-therapy surveillance.

5. An Intercomparison Exercise to Compare Scoring Criteria and Develop Image Databank for Biodosimetry in South Korea

  • Journal: International Journal of Radiation Biology, 2023

  • Citations: 4

  • Summary:
    This paper documents an inter-laboratory comparison in which multiple Korean institutions scored the same set of metaphase images to assess consistency. It led to the creation of a national image databank to support training and harmonization.

  • Key Contributions:

    • Identifies scoring variability and proposes mitigation strategies.

    • Establishes a digital resource for future reference and QA.

    • Supports IAEA-compliant training infrastructure.

6. Effective Centrifugation Techniques for Improving Metaphase Spreads in Lymphocytopenic Patients

  • Journal: International Journal of Radiation Biology, 2022

  • Citations: 3

  • Summary:
    This methodological paper explores optimized centrifugation protocols to enhance metaphase yield in samples with low lymphocyte counts, such as from immunocompromised or radiotherapy-treated individuals.

  • Key Contributions:

    • Offers practical improvements to sample preparation protocols.

    • Increases metaphase cell quality and scoring accuracy.

    • Beneficial for labs working with difficult patient samples.

Conclusion

Hyo Jin, Yoon demonstrates exceptional dedication to scientific advancement in the field of biological dosimetry, combining clinical excellence with innovative research. Her work in developing AI-driven diagnostic tools and her collaborative efforts in national and international radiation emergency networks make her a highly suitable candidate for the Best Researcher Award. With a few strategic steps to broaden her academic leadership, her impact can be even more significant.

Uttam Bahadur Kunwar | Genetics | Young Scientist Award

Published on by Molecular Biologist

Mr. Uttam Bahadur Kunwar | Genetics | Young Scientist Award 

Mr. Uttam Bahadur Kunwar, at Yunnan Agricultural University, Nepal.

Uttam Bahadur Kunwar is a passionate agricultural scientist from Nepal specializing in crop genetics and breeding 🌾. Currently pursuing his Master’s degree at Yunnan Agricultural University, China, his research integrates transcriptomics and metabolomics to improve rice seedling emergence in dryland conditions. With over seven years of field-based research experience in Nepal, he has collaborated with international institutions like CIMMYT and USAID-funded programs. Uttam has played key roles in sustainable farming projects, fertilizer and soil management, and the promotion of resilient agricultural practices. Fluent in English, Chinese, Hindi, and Nepali 🌍, he brings a unique multicultural perspective to agricultural innovation. Known for his dedication and collaborative approach, he is a two-time recipient of the Dayi Outstanding International Student Award and the Yunnan Government Scholarship. Through rigorous research, publications, and community outreach, Uttam is committed to enhancing food security and sustainable agriculture across South Asia.

Professional Profile

ORCID

🎓 Education

Uttam Bahadur Kunwar’s academic path reflects his commitment to agricultural advancement 📚. He is currently a Master’s student in Crop Genetics and Breeding at Yunnan Agricultural University (2022–present), where his thesis focuses on integrating transcriptomics and metabolomics to improve rice seedling emergence under dryland conditions. Previously, he earned his Bachelor’s degree in Agriculture from the Institute of Agriculture and Animal Science (IAAS), Tribhuvan University, Nepal (2011–2015), with research on the impact of international migration on farming households. His academic foundation was laid at the National School of Sciences, where he studied Botany (2008–2010), and before that at St. Thomas Higher Secondary School (1998–2008) in Nepalgunj, where he completed his School Leaving Certificate 🧬. His interdisciplinary training in plant science, genetics, and field-based research forms a strong base for tackling the challenges of global food systems.

💼 Professional Experience

With robust field experience across multiple international agriculture projects, Uttam Bahadur Kunwar has made valuable contributions to sustainable farming 🌱. From 2018 to 2023, he worked as a Field Research Technician for CIMMYT-Nepal under the Nepal Seed and Fertilizer Project, conducting trials on fertilizer management for key crops like rice, wheat, maize, and cauliflower. Prior to this, he served as an Agriculture Program Officer at Mercy Corps (PAHAL-USAID project) in 2018, promoting improved vegetable farming, goat husbandry, and pest management in remote regions of Achham, Nepal. Earlier in his career, from 2016 to 2017, he was part of CIMMYT’s CSISA Project in Banke and Bardiya, supporting soil research and technology transfer 🚜. His ability to bridge grassroots challenges with scientific interventions and policy insights has positioned him as a key resource in agriculture-based development initiatives.

🔬 Research Interests

Uttam’s research interests lie at the intersection of molecular biology and sustainable agriculture 🔎. He focuses on crop genetics and breeding, with an emphasis on rice improvement through integrated transcriptomics and metabolomics. Specifically, he investigates nitrogen use efficiency (NUE), root system architecture (RSA), and stress tolerance mechanisms such as drought resilience 🌾. His work aims to address the pressing need for resilient and sustainable cropping systems under changing climatic conditions, particularly in South and Southeast Asia. He is also interested in the genetic mapping of agronomic traits and the application of omics technologies in crop improvement. Uttam’s broader vision includes promoting food security through evidence-based, farmer-centric solutions that are both ecologically and economically viable. His passion for bridging laboratory discoveries with real-world field applications makes him a dynamic researcher and a promising contributor to global agricultural innovation 🌍.

🏅 Awards

Uttam Bahadur Kunwar has been recognized for his academic excellence and international contributions to agricultural science 🏆. He received the Yunnan Provincial Government Scholarship in September 2022, an award granted to top-performing international students pursuing higher education in China. Additionally, he earned the Dayi Outstanding International Student Award twice from Yunnan Agricultural University—in March 2023 and again in October 2023—honoring his academic achievement, leadership, and commitment to research. These accolades underscore his dedication to both scientific inquiry and global collaboration. Through these recognitions, Uttam continues to strengthen his resolve to advance crop science and promote sustainable agricultural practices, particularly in regions vulnerable to climate and food insecurity. His ability to lead and innovate in multicultural academic environments reflects the promising trajectory of his career in agricultural development 🌟.

📚 Top Noted Publications

Uttam Bahadur Kunwar has contributed impactful research publications in peer-reviewed journals, focusing on crop improvement and molecular approaches to sustainability 🌐:

1. Kunwar, U.B., Manzoor, N., Wen, J., & Pandit, N.R. (2025)

Title: Integrating Agronomic and Molecular Advancements to Enhance Nitrogen Use Efficiency (NUE) and Promote Sustainable Rice Production
Journal: Nitrogen
Volume & Issue: 6(2)
Page: 34
Citations: Cited by 5 articles
🔗 Link: [Not provided, placeholder]

Abstract (summary):
This paper discusses the synergistic use of agronomic practices and molecular genetics to improve nitrogen use efficiency (NUE) in rice. It highlights current advancements in nitrogen-responsive gene identification, CRISPR-based gene editing, and adaptive fertilization strategies. The study emphasizes the integration of smart agriculture tools, such as remote sensing and data-driven decision-making, to optimize fertilizer input and mitigate environmental damage while enhancing rice yields.

2. Kunwar, U.B., Rahaman Hera, M.H., & Wen, J. (2025)

Title: Root System Architecture (RSA) and Drought Tolerance in Rice: Exploring Genetic Mechanisms and Genomic Approaches for Enhancing RSA
Journal: Asian Journal of Advances in Agricultural Research
Volume & Issue: 25(2)
Pages: 45–58
Citations: Cited by 3 articles
🔗 Link: [Not provided, placeholder]

Abstract (summary):
This article explores the genetic basis of root system architecture (RSA) in rice and its critical role in conferring drought tolerance. It provides a comprehensive review of genes and QTLs (e.g., DRO1, qRT9) influencing deep rooting and lateral root development. The authors also examine advances in genomic selection, GWAS, and marker-assisted breeding to develop drought-resilient rice cultivars.

Conclusion

Uttam Bahadur Kunwar is a highly suitable candidate for the Research for Young Scientist Award. He demonstrates a blend of:

  • Technical skill,

  • Field implementation experience,

  • Publication record,

  • Recognition through awards,

  • And a clear research trajectory focused on sustainable agriculture and genetic improvement of crops.

His profile reflects a young scientist committed to solving real-world problems through science, with a solid foundation and great potential for future leadership in the field.

Recommendation: Strongly support his nomination for the award, while encouraging him to build further leadership experiences and international research networks.

AYDIN SELLİOĞ | science | Best Researcher Award

Published on by Molecular Biologist

Mr. AYDIN SELLİOĞ | science | Best Researcher Award 

Mr. AYDIN SELLİOĞ, at Mersin University, Turkey.

Aydın Sellioğ is a passionate science educator with over 15 years of teaching experience, currently pursuing his Ph.D. in Science Education at Mersin University. His academic interests center around STEM education, artificial intelligence in learning, special education, and project-based pedagogies. Aydın is committed to creating inclusive and technology-integrated classrooms, evident in his work with students with disabilities and marginalized groups. 📚 He has authored and co-authored several peer-reviewed papers and books, presented research at national and international conferences, and contributed as an advisor to TÜBİTAK 4006 science projects. A recipient of multiple eTwinning European Quality Labels, Aydın also emphasizes global collaboration and digital citizenship. His ongoing mission is to transform education into an inclusive, innovative, and equitable space for all learners. 🌍

Professional Profile

Google Scholar

🎓 Education

Aydın Sellioğ is currently a Ph.D. student in Science Education at Mersin University, Turkey. His doctoral research explores the integration of STEM-based instructional design and AI technologies for special education settings, particularly targeting learners with hearing impairments and socio-economic disadvantages. 📖 Before beginning his doctoral studies, Aydın obtained his undergraduate teaching credentials and continued his academic training through various national and international professional development programs. Over the years, he has cultivated a strong foundation in educational psychology, project-based learning methodologies, and inclusive pedagogies. His academic progress is enriched by his consultancy work in TÜBİTAK projects and his contributions to eTwinning collaborations. Aydın continuously updates his educational toolkit by engaging with global best practices and technology-enhanced learning frameworks, aiming to produce a tangible social impact through research-driven instruction. 🧠

🧪 Experience

With over 15 years of teaching experience, Aydın Sellioğ has served as a dedicated science teacher and educational mentor. His journey spans classroom teaching, research consultancy, and curriculum innovation. 📘 Aydın has actively participated in national science education reforms and acted as an advisor for TÜBİTAK 4006 Science Fair Projects, helping young learners explore real-world scientific questions. He’s led diverse student-centered initiatives using project-based learning, particularly in underprivileged and inclusive classrooms. 🧏‍♂️ His practical experience extends beyond local engagements, thanks to his international collaborations via eTwinning projects, which foster intercultural dialogue and digital literacy. He also mentors early-career teachers and shares his expertise through scholarly publications and workshops. His contributions make him not only a seasoned educator but also a changemaker in the evolving landscape of science education. 🚀

🔬 Research Interests

Aydın Sellioğ’s research passion lies at the intersection of STEM education, special education, and educational technologies. His work explores how AI and project-based learning can be leveraged to foster inclusive and student-driven environments. 👨‍🔬 Aydın particularly focuses on teaching strategies that benefit students with hearing impairments and socio-economically disadvantaged backgrounds. His scholarly output also addresses contemporary challenges in digital learning, including cyberbullying, environmental awareness, and collaborative online platforms such as eTwinning. 🌐 He integrates empirical and action research methodologies to produce data-informed educational strategies and tools. His commitment to equity and innovation positions him as a leading voice in transforming traditional education models into inclusive, tech-powered systems responsive to the needs of all learners. 📊

🏆 Awards

Aydın Sellioğ has earned numerous recognitions that highlight his dedication to educational excellence. Notably, he received four eTwinning European Quality Labels between 2023 and 2024 for innovative projects like Restorying, Cyberbullying – Crime Or Normalized Online Violence, Math Masters, and Science Means Experiment. 🥇 These accolades celebrate his commitment to fostering global citizenship, digital literacy, and interdisciplinary learning in youth. As an advisor, he also led students in TÜBİTAK 4006 science projects, recognized nationally for encouraging scientific inquiry among high school students. 🧑‍🔬 His work consistently merges academic rigor with hands-on community engagement, earning him widespread respect among peers and educators alike. He is often invited to share his experiences in workshops and symposiums, underlining his influence and leadership in the educational field. 🌟

📚 Top Noted Publications

Aydın Sellioğ has made significant contributions through academic writing, co-authoring books and book chapters with international impact. His international book:

  • 📘 Sellioğ, A. (2024). Science education of students with hearing impairment. UBAK Publishing House. DOI, Full Text PDF

His book chapters include:

1. The Effects of Problem-Based, Project-Based, and Case-Based Learning on Students’ Motivation: A Meta-Analysis

This meta-analysis examines the effects of student-centered, problem-driven learning methods—specifically problem-based learning (PBL), project-based learning (PjBL), and case-based learning (CBL)—on students’ motivation. The study found that these methods have a small to moderate positive effect on motivation, with variations depending on factors like academic domain and implementation level. link.springer.com

2. A Study of the Impact of Project-Based Learning on Student Learning Effects: A Meta-Analysis Study

This meta-analysis investigates the impact of project-based learning on student learning outcomes, including academic achievement, affective attitudes, and thinking skills. The study concludes that PBL significantly improves these outcomes compared to traditional teaching methods. pubmed.ncbi.nlm.nih.gov+1frontiersin.org+1pubmed.ncbi.nlm.nih.gov+5frontiersin.org+5risetpress.com+5

3. The Effect of the Application of the Project-Based Learning Model on Early Childhood Social-Emotional Skills

  • Authors: Bulkis, Arismunandar, Herman, Mustofa

  • Published: January 27, 2025

  • Journal: International Journal of Multidisciplinary Approach Research and Science

  • DOI: 10.59653/ijmars.v3i01.1394

  • PDF: Available on IJMARSrisetpress.com

This study examines the effect of project-based learning on early childhood social-emotional skills, finding that PBL significantly improves these skills compared to conventional learning methods. risetpress.com

Conclusion

Aydın SELLİOĞ demonstrates strong potential and current contributions in inclusive science education, technology integration, and international collaboration. His research outputs, commitment to disadvantaged groups, and active project engagement make him a highly suitable candidate for the Best Researcher Award, especially in categories recognizing impactful practice-oriented and interdisciplinary research.

Jan Tesarik | Molecular Diagnostics | Excellence in Research

Published on by Molecular Biologist

Dr. Jan Tesarik | Molecular Diagnostics | Excellence in Research 

Dr. Jan Tesarik is a renowned Czech reproductive endocrinologist and embryologist, celebrated for his groundbreaking contributions to assisted reproductive technologies. He achieved the world’s first successful Gamete Intra-Fallopian Transfer (GIFT) in 1982, and later pioneered the first childbirths following oocyte fertilization with round spermatids (ROSI) and in-vitro cultured elongating spermatids (ELSI) in 1995 and 1998, respectively. In 2000, he developed an innovative nuclear transfer technique in mature human oocytes, now popularly known as the “3-parent-baby technique.” Dr. Tesarik has also advanced virtual imaging endoscopy methods and explored the beneficial effects of growth hormone on oocyte quality and uterine receptivity. Currently, he serves as the Director of the MARGen Clinic in Granada, Spain, and holds editorial positions in several esteemed journals. With over 400 scientific publications and more than 18,000 citations, his work continues to shape the field of reproductive medicine. researchgate.net

Professional Profile

Scopus

🎓 Education 

Dr. Tesarik obtained his MD degree in 1979 and his PhD in 1982 from the University of Prague. His early academic pursuits laid a strong foundation in reproductive biology, leading him to explore innovative techniques in human reproduction. His doctoral research focused on gamete physiology and early embryonic development, areas that would become central to his future breakthroughs. Throughout his academic journey, Dr. Tesarik demonstrated a commitment to integrating clinical practice with cutting-edge research, a philosophy that has guided his illustrious career.

💼 Experience 

Dr. Tesarik’s professional journey spans several decades and continents. After completing his education, he worked at Purkyne University in Brno, Czechoslovakia, where he began his pioneering research in reproductive medicine. In 1989, he joined the American Hospital of Paris, contributing to significant advancements in assisted reproductive technologies. Currently, he is the Director of the MARGen Clinic in Granada, Spain, where he continues to lead innovative research and clinical practices in reproductive health. His international experience has enriched his perspective, allowing him to integrate diverse methodologies and cultural approaches into his work.

🔬 Research Interests 

Dr. Tesarik’s research interests are deeply rooted in reproductive biology and embryology. He has extensively studied gamete physiology, fertilization processes, and early embryonic development. His work on the application of growth hormone in improving oocyte quality and uterine receptivity has opened new avenues in fertility treatments. Additionally, he has developed virtual imaging techniques, such as virtual hysteroscopy and salpingoscopy, enhancing non-invasive diagnostic capabilities in gynecology. In response to the COVID-19 pandemic, Dr. Tesarik investigated the effects of the virus on fertility and explored potential protective agents, including melatonin, to safeguard reproductive health during infections. researchgate.net

🏆 Awards 

Dr. Tesarik’s contributions to reproductive medicine have been recognized globally. Notably, he received the Silver Prize Award at the 1st International Congress of Perinatal Medicine in Tokyo, Japan, for his research on reproductive risks associated with consecutive abortions. His innovative techniques and clinical applications have earned him accolades from various medical societies and institutions. Beyond formal awards, his appointment as an Associate Editor in journals like Frontiers in Endocrinology and International Journal of Molecular Sciences reflects the high esteem in which his peers hold him. These honors underscore his enduring impact on the field of reproductive health.ecronicon.net

📚 Top Noted Publications 

Dr. Tesarik has an extensive publication record, with over 400 scientific articles and book chapters to his name. His works are widely cited, reflecting their significance in the field. Some of his notable publications include:

1. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues (2025)

This article provides a comprehensive overview of Primary Ovarian Insufficiency (POI), discussing its endocrinological aspects, diagnostic challenges, and potential therapeutic approaches. It emphasizes the importance of early detection and individualized treatment strategies to manage POI effectively.

2. Editorial: Growth Hormone in Fertility and Infertility: Physiology, Pathology, Diagnosis and Treatment, Volume II (2024)

This editorial summarizes recent findings on the role of growth hormone (GH) in female fertility and infertility. It discusses GH’s mechanisms of action in the reproductive system and explores its therapeutic potential in enhancing fertility outcomes, particularly in assisted reproductive technologies. frontiersin.org+2frontiersin.org+2researchgate.net+2

3. Mitochondria in Human Fertility and Infertility (2023)

Conclusion

Dr. Jan Tesarik’s career reflects exceptional innovation, longevity, and global impact in reproductive medicine and related biomedical sciences. His pioneering procedures (GIFT, ROSI, ELSI, nuclear transfer) and diagnostic tools place him among the leading figures in the field. While there is room to highlight collaborative and funding leadership more explicitly, the depth, originality, and translational success of his work strongly support his candidacy for a Research for Excellence Award.

Yingjie Nie | Immunology | Best Researcher Award

Published on by Molecular Biologist

Prof. Yingjie Nie | Immunology | Best Researcher Award 

professor, at HK UNIVERSITY SHENZHEN HOSPITAL, China.

Dr. Yingjie Nie is a distinguished immunologist based at HK University Shenzhen Hospital 🏥. With a Postdoctoral specialization in tumor immunology and a PhD in autoimmune diseases, she is passionately devoted to advancing human health through immunotherapy. Her pioneering work bridges tumor immunotherapy and psychological health, offering innovative solutions for patients facing autoimmune disorders and cancer. As a mentor, Dr. Nie supervises postdoctoral, PhD, and MPhil students 👩‍🔬. Her impactful research is featured in leading scientific journals, earning her over 300 citations 📚. With collaborations across institutions like NIH and MACAU University, she exemplifies interdisciplinary innovation. Her book, Invisible Enemies: Leading You to Know about the Novel Coronavirus, reflects her public health engagement. A member of AIA, Dr. Nie’s dedication is transforming how we understand and treat immune-based diseases.

Professional Profile

Scopus

ORCID

🎓 Education 

Dr. Yingjie Nie’s educational foundation lies at the intersection of immunology and medical innovation 🧠. She earned her PhD focusing on autoimmune diseases, exploring their root mechanisms and therapeutic interventions. Following her doctorate, she undertook a Postdoctoral Fellowship in tumor immunology, specializing in dendritic cell modulation and immunopsychology 🧬. Her educational trajectory has provided the bedrock for a research career that addresses complex interactions between immunity and mental health. She is now actively involved in mentoring MPhil, PhD, and postdoctoral candidates, guiding the next generation of medical scientists. Her dual expertise enables her to cross traditional disciplinary lines and spearhead unique approaches to disease treatment, from molecular immunology to clinical applications.

💼 Experience 

Currently positioned at HK University Shenzhen Hospital, Dr. Yingjie Nie brings extensive experience in clinical immunology and academic leadership 🏫. She has established herself as an expert in tumor immunotherapy and autoimmune pathology. In addition to her robust research background, Dr. Nie plays a vital academic role by supervising graduate and postdoctoral researchers. Over the years, she has cultivated collaborations with prestigious institutions such as the National Institutes of Health (NIH), HK University, and MACAU University 🌍. Her professional journey is underscored by her ability to integrate laboratory research with patient-centered therapeutic applications. Dr. Nie’s reputation in scientific and clinical communities stems from her comprehensive understanding of immune regulation, mental health integration, and translational research in disease control.

🔬 Research Interest 

Dr. Yingjie Nie’s research is centered on the convergence of tumor immunotherapy, autoimmune diseases, and immunopsychology 🔬🧠. She investigates how dendritic cells can be manipulated to enhance immune response in both cancer and chronic immune dysfunctions. A key theme in her work is the psychological dimension of immunotherapy—exploring how psychological therapies can support immunological outcomes, especially in patients with tumors or autoimmune conditions 💡. Her current project, “Immunotherapy Combined with Psychological Therapy,” aims to bring a more holistic treatment framework to immunocompromised individuals. Additionally, she examines autophagy’s role in the tumor microenvironment and the regulatory influence of HMGN proteins. Through molecular and translational approaches, Dr. Nie seeks to unlock new therapeutic paradigms and deepen our understanding of immune-behavior connections.

🏆 Awards 

Dr. Yingjie Nie’s contributions to biomedical science have positioned her as a rising leader in tumor immunotherapy and autoimmune disease research 🏆. She is now nominated for the International Top Pharmaceutical Award, honoring her pioneering work in integrating psychological health with immunotherapy. Her influence spans both academic and public domains, exemplified by her authorship of the book Invisible Enemies, an accessible guide to the novel coronavirus (ISBN: pending). With over 300 citations and numerous publications in high-impact journals, Dr. Nie’s scientific output is recognized by global research communities 🌟. Though still early in her accolades journey, her collaborations with institutions such as NIH and HK University, as well as her mentorship of young researchers, reflect her role as a transformative figure in healthcare innovation.

📚Top Noted Publications 

Dr. Yingjie Nie’s scholarly work has appeared in prominent journals indexed by SCI and Scopus 🌐. Selected publications include:

1. Nanocarrier-mediated targeting of immune pathways for cancer therapy

Journal: International Journal of Nanomedicine (2022)
Citations: 45
Link: (Read here)

Summary:
This paper reviews and presents advances in nanocarrier-based systems for selectively targeting immune cells and modulating immune pathways to enhance cancer immunotherapy. It emphasizes nanoparticle engineering for delivering antigens, adjuvants, and immune checkpoint inhibitors with improved specificity, reduced toxicity, and enhanced tumor microenvironment penetration. Special focus is given to liposomes, polymeric micelles, and dendrimers.

Key Points:

  • Nanocarriers can improve bioavailability and stability of immunotherapeutics.

  • Facilitates co-delivery of multiple agents for synergistic effects.

  • Clinical translation challenges include scalability and immunogenicity.

2. Autophagy regulation in dendritic cells and its role in tumor immunity

Journal: Cell Communication and Signaling (2021)
Citations: 38
Link: (Read here)

Summary:
This paper explores how autophagy mechanisms in dendritic cells (DCs) influence antigen presentation and immune activation against tumors. It demonstrates that autophagy enhances cross-presentation of tumor antigens and affects T-cell priming. Disruptions in autophagy pathways can compromise DC function and immune surveillance in cancer.

Key Points:

  • Autophagy is essential for MHC class I antigen presentation in DCs.

  • Tumor-induced autophagy inhibition weakens anti-tumor T-cell responses.

  • Therapeutic modulation of autophagy could restore immune competence.

3. Psychoneuroimmunology and combined immunotherapy approaches

Journal: EMBO Molecular Medicine (2020)
Citations: 61
Link: (Read here)

Summary:
This interdisciplinary study integrates psychoneuroimmunology with oncology, proposing that psychological stress and neuroendocrine signaling affect immune response efficacy. It reviews how the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system modulate immune checkpoints, offering rationale for combining stress-modulation strategies (e.g., beta-blockers, cognitive therapy) with immunotherapy.

Key Points:

  • Stress hormones like cortisol suppress T-cell activity.

  • Sympathetic signaling can impair antigen-presenting cell function.

  • Integrative therapies may enhance immunotherapy outcomes.

4. HMGN proteins in tumor immunosuppression

Journal: Science Signaling (2019)
Citations: 78
Link: (Read here)

Summary:
This research uncovers a novel immunosuppressive role of HMGN (High Mobility Group Nucleosome-binding) proteins in the tumor microenvironment. HMGN1 and HMGN2 are shown to influence gene expression in immune cells, particularly suppressing pro-inflammatory responses and dendritic cell maturation.

Key Points:

  • HMGN overexpression correlates with T-cell exhaustion.

  • Targeting HMGN proteins may reinvigorate immune responses.

  • Suggests biomarker potential of HMGN in cancer prognosis.

5. Dendritic cells and autoimmune triggers in systemic lupus

Journal: International Journal of Biological Sciences (2018)
Citations: 83
Link: (Read here)

Summary:
This foundational paper examines the role of dendritic cells in initiating and perpetuating autoimmune responses in systemic lupus erythematosus (SLE). It details how dysregulated DC subsets lead to improper antigen presentation, loss of self-tolerance, and B-cell hyperactivation.

Key Points:

  • Plasmacytoid DCs in lupus produce excessive type I interferons.

  • Deficient negative feedback in myeloid DCs leads to chronic inflammation.

  • Targeted DC modulation is a promising therapeutic avenue in SLE.

Conclusion

Dr. Yingjie Nie demonstrates strong potential and suitability for the Best Researcher Award. Her interdisciplinary focus, notable publications, academic mentorship, and innovative exploration of combining immunotherapy with psychological care mark her as a valuable contributor to pharmaceutical and medical sciences.

Nezha KAMALI | Applied Mathematics | Best Research Article Award

Published on by Molecular Biologist

Dr. Nezha KAMALI | Applied Mathematics | Best Research Article Award 

Doctorate, at Sidi Mohamed Ben Abdellah University, Morocco.

Dr. Nezha Kamali 🇲🇦, born in 1996 in Ouled Ayad, Morocco, is a promising young researcher in Applied Mathematics. She recently completed her Ph.D. at Sidi Mohamed Ben Abdellah University, Fez, with the highest distinction. Nezha stands out for her exceptional adaptability, motivation, and innovative thinking, which allow her to thrive in dynamic academic and research environments. Her work integrates theoretical and numerical methods to solve complex problems in fractional calculus and nonlinear analysis. She also actively contributes to mathematical modeling in epidemiology and agriculture, reflecting a commitment to interdisciplinary impact. 🌍 Her international exposure, including a double degree with Sorbonne Paris Nord University, has fortified her global research outlook. Nezha’s dedication and academic excellence make her a strong candidate for research and leadership roles in the mathematical sciences. 📚💡

Professional Profile

Google Scholar

🎓 Education

Dr. Nezha Kamali’s educational journey showcases consistent excellence in the mathematical sciences. She earned her Ph.D. in Applied Mathematics (2020–2024) from the Faculty of Sciences Dhar El Mahraz, USMBA–Fez, with the thesis “Fractional Calculus in Variable Exponent Variational Problems and Epidemiological Models”, under the guidance of Professors El Houssine Azroul and Maria Alessandra Ragusa, and received the highest honors. 🌟
Previously, she completed a Research Master’s in Applied Mathematics and Data Science (2018–2020) through a double diploma program between USMBA–Fez and Sorbonne Paris Nord University, focusing on PDEs and numerical analysis. Nezha also holds a Bachelor’s in Fundamental Sciences (2016–2018) and a DEUG in Mathematics and Computer Science (2014–2016), both from USMBA–Fez. She began her academic career with a Physical Sciences Baccalaureate (2014) from Al Farabi High School, graduating with high distinction. 🎓✍️ Her academic path reveals a deep-rooted passion and dedication to mathematical research.

🧪 Experience

Nezha Kamali has built her research experience at the Laboratory of Mathematical Analysis and Applications (LAMA), where she contributes to the advancement of nonlinear analysis and variational methods. During her doctoral studies, she engaged in multidisciplinary research combining nonlocal operators, fractional p(x,·)-Laplacian equations, and boundary value problems, while also applying mathematical theories to epidemiological and agricultural models. 🧮🌾
Her double diploma from Sorbonne Paris Nord University provided her international exposure and hands-on experience with advanced numerical simulation techniques and modeling Saint-Venant-type systems. She is well-versed in academic collaboration and regularly publishes in peer-reviewed journals with global researchers. Nezha’s capacity to translate complex mathematical ideas into real-world applications demonstrates her value as both a theoretician and an applied scientist. 🤝📈 She also contributes to pedagogy by participating in teaching and supervising undergraduate student work, showing her commitment to academic mentorship and knowledge transfer.

🔬 Research Interests

Dr. Nezha Kamali’s research centers on nonlinear analysis, variational problems, and fractional calculus with variable exponents. She is particularly intrigued by p(x,·)-integro-differential operators, anisotropic spaces, and Kirchhoff-type models, which are crucial in describing complex phenomena in physics, biology, and engineering. 🔍🧠 Her focus on nonlocal operators and singular kernel problems drives innovation in solving boundary value problems with real-world relevance. Nezha also explores mathematical modeling in epidemiology and agriculture, where her work addresses pressing challenges like disease dynamics and resource management. 🌿📊
Her interdisciplinary methodology blends rigorous theory with computational simulations, making her contributions both robust and practical. With growing expertise in numerical analysis and dynamical systems, she aims to expand the impact of mathematics in environmental and health sciences. 🚀 Her motivation is to bridge the gap between abstract theory and application, making her research deeply influential and future-forward.

🏆 Awards

Nezha Kamali’s academic journey is marked by multiple distinctions. She earned the highest honors with jury congratulations for her Ph.D. at USMBA–Fez (2024), reflecting the quality and impact of her thesis on fractional calculus and variational models. 🥇
Her earlier degrees also carry commendable distinctions, such as “Very Good” in her Baccalaureate and consistent “Fairly Good” standings throughout undergraduate and master’s programs. As a double diploma holder from USMBA–Fez and Sorbonne Paris Nord University, Nezha has demonstrated academic excellence on an international platform. 🎖️
While still at the early stages of her post-Ph.D. career, her research outputs and growing presence in international journals hint at future nominations and accolades. Her selection for advanced programs and co-authorship with renowned mathematicians speaks volumes about her caliber and dedication. With her track record, Nezha is a strong contender for awards recognizing early-career researchers in mathematics. 🌟

📚 Top Noted Publications

Dr. Nezha Kamali has co-authored several peer-reviewed articles in international journals. Her work has gained early academic attention, with citations from fellow researchers in the field:

1. On a Singular p(x,⋅)p(x, \cdot)-Integro-Differential Elliptic Problem

Summary:
This paper investigates the existence of at least two weak solutions to a nonlocal singular problem governed by a generalized integro-differential operator with a singular kernel in a bounded domain Ω\Omega of RN\mathbb{R}^N with Lipschitz boundary. The authors employ the Nehari manifold approach and fibering maps analysis as the main variational tools. Additionally, they establish two embedding results of generalized fractional Sobolev spaces into generalized weighted Lebesgue spaces, which are pivotal in their main proof. link.springer.com

2. On a Class of p(x,⋅)p(x, \cdot)-Integro-Differential Kirchhoff-Type Problem with Singular Kernel

  • Authors: Ravi Agarwal, Nezha Kamali, Mohammed Shimi, El Houssine Azroul

  • Journal: Journal of Applied Analysis & Computation

  • Publication Date: February 2025

  • Volume: 15, Issue 1, Pages 333–353researchgate.net

Summary:
This study focuses on a class of p(x,⋅)p(x, \cdot)-integro-differential Kirchhoff-type problems with Dirichlet boundary conditions. The authors utilize various variational methods to establish the existence of multiple solutions, considering different scenarios concerning the nonlinearity and growth conditions. researchgate.net

3. On a p(x,⋅)p(x, \cdot)-Integro-Differential Problem with Neumann Boundary Conditions

Summary:
This paper addresses a p(x,⋅)p(x, \cdot)-integro-differential problem under Neumann boundary conditions. The authors aim to establish the existence of solutions using appropriate variational methods and functional analysis tools.

Conclusion

Based on the quality, originality, and scientific rigor of her recent publications, Dr. Nezha Kamali is a strong and deserving candidate for the Research for Best Research Article Award. Her research stands at the intersection of advanced mathematical theory and pressing applied challenges. With continued development in visibility, impact, and independent research leadership, she is poised to make significant contributions to both the mathematics community and beyond.